The myeov gene has been isolated by the tumorigenicity assay and is localized at chromosome 11q13, a frequent site for chromosomal rearrangements in various carcinomas and B-cell neoplasms. In addition myeov is coamplified with cyclinD1 (CCND1) and overexpressed in carcinomas of various organs. The mechanisms of myeov regulation remain enigmatic. The 5’ untranslated region (5’-UTR) of the myeov gene is long, encompasses several upstream AUGs and is predicted to fold in a strong secondary structure suggesting that its translation might be regulated by an internal ribosomal entry site (IRES). Here we show that initial experiments using monocistronic and dicistronic reporter constructs supported this assumption. However the application of in vitro transcription/translation assays, Northern blot analysis and promoterless dicistronic constructs revealed promoter activity of the myeov 5’-UTR. DNA transfection of dicistronic DNA constructs, normal and mutated forms of myeov cDNA fragments cloned in an eukaryotic expression vector and direct RNA transfection analysis revealed that upstream AUG triplets in the 5’-UTR of the myeov transcript abrogate translation. Alternative splicing mechanisms in specific cell types and/or developmental stage may evade this translation control. Control experiments suggest that the 5’-UTR from encephalomyo-carditis virus (EMCV), when inserted at the midpoint of a dicistronic vector, is also able to function as a cryptic promoter.